Evidence check: Fertility Check | Fruchtbarkeits-Test in the context of Langlebigkeit

A fertility test (e.g., AMH, FSH, estradiol) provides information about current ovarian reserve and hormonal status, but does not directly measure longevity. The evidence linking fertility markers to overall lifespan is weak to moderate: low AMH may indicate accelerated ovarian aging, which is associated with earlier menopause and potentially reduced reproductive healthspan. However, effects on total mortality are small and confounded by lifestyle. MyBody-X may offer such tests, but the provided context contains no specific data on fertility tests. Therefore, the evidence grade is 'marketing/unclear'. A fertility test alone cannot guide longevity recommendations. Comprehensive longevity assessment requires additional biomarkers (glucose, lipids, inflammation) and clinical evaluation. Caveat: Not diagnostic or prognostic; always interpret with a physician.